Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-Assembly process of α-hemolysin

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wang, Jianfeng ^a   Zhou, Xuan ^a   Li, Wenhua ^a   Deng, Xuming ^a   Deng, Yanhong ^a   Niu, Xiaodi ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL TOXIN; CURCUMIN; HEMOLYSIN; PROTECTIVE AGENT; VIRULENCE FACTOR;

ANIMAL; C57BL MOUSE; DRUG EFFECTS; FEMALE; HEMOLYSIS; METABOLISM; METHICILLIN RESISTANCE; MOUSE; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CURCUMIN; FEMALE; HEMOLYSIN PROTEINS; HEMOLYSIS; METHICILLIN RESISTANCE; MICE; MICE, INBRED C57BL; PNEUMONIA, STAPHYLOCOCCAL; PROTECTIVE AGENTS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84976613126     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28254     Document Type: Article

References (40)

1. Elston, D. M. Community-Acquired methicillin-resistant Staphylococcus aureus. Journal of the American Academy of Dermatology 56, 1-16 (2007).
2. Rivera, A. M. & Boucher, H. W. Current concepts in antimicrobial therapy against select gram-positive organisms: methicillinresistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc. 86, 1230-1243 (2011).
3. Rasko, D. A. & Sperandio, V. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov. 9, 117-128 (2010).
4. Ragle, B. E., Karginov, V. A. & Bubeck Wardenburg, J. Prevention and treatment of Staphylococcus aureus pneumonia with a betacyclodextrin derivative. Antimicrobial agents and chemotherapy. 54, 298-304 (2010).
5. Qiu, J. et al. Baicalin protects mice from Staphylococcus aureus pneumonia via inhibition of the cytolytic activity of alphahemolysin. The Journal of infectious diseases 206, 292-301 (2012).
6. Khodaverdian, V. et al. Discovery of antivirulence agents against methicillin-resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy 57, 3645-3652 (2013).
7. Nguyen, V. T. & Kamio, Y. Cooperative assembly of beta-barrel pore-forming toxins. J Biochem. 136, 563-567 (2004).
8. Song, L. et al. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274, 1859-1866 (1996).
9. Bubeck Wardenburg, J., Bae, T., Otto, M., Deleo, F. R. & Schneewind, O. Poring over pores: Alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nature medicine 13, 1405-1406 (2007).
10. Berube, B. J. & Bubeck Wardenburg, J. Staphylococcus aureus alpha-Toxin: nearly a century of intrigue. Toxins 5, 1140-1166 (2013).
11. Montgomery, C. P., Boyle-Vavra, S. & Daum, R. S. Importance of the global regulators Agr and SaeRS in the pathogenesis of CAMRSA USA300 infection. Plos one 5, e15177 (2010).
12. Montgomery, C. P. et al. Comparison of virulence in community-Associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. The Journal of infectious diseases 198, 561-570 (2008).
13. Esatbeyoglu, T. et al. Curcumin-from molecule to biological function. Angew Chem Int Ed Engl. 51, 5308-5332 (2012).
14. Shehzad, A., Rehman, G. & Lee, Y. S. Curcumin in inflammatory diseases. BioFactors 39, 69-77 (2013).
15. Sinha, D., Biswas, J., Sung, B., Aggarwal, B. B. & Bishayee, A. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Current drug targets 13, 1799-1819 (2012).
16. Gao, W., Chan, J. Y., Wei, W. I. & Wong, T. S. Anti-cancer effects of curcumin on head and neck cancers. Anti-cancer agents in medicinal chemistry 12, 1110-1116 (2012).
17. Kapakos, G., Youreva, V. & Srivastava, A. K. Cardiovascular protection by curcumin: molecular aspects. Indian journal of biochemistry & biophysics 49, 306-315 (2012).
18. Dong, J. et al. Oroxylin A inhibits hemolysis via hindering the self-Assembly of alpha-hemolysin heptameric transmembrane pore. Plos Comput Biol. 9, e1002869 (2013).
19. Bubeck Wardenburg, J. & Schneewind, O. Vaccine protection against Staphylococcus aureus pneumonia. The Journal of experimental medicine 205, 287-294 (2008).
20. Walker, B. & Bayley, H. Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alphahemolysin identified by cysteine scanning mutagenesis and targeted chemical modification. The Journal of biological chemistry 270, 23065-23071 (1995).
21. Schaffner-Barbero, C. et al. Insights into nucleotide recognition by cell division protein FtsZ from a mant-GTP competition assay and molecular dynamics. Biochemistry 49, 10458-10472 (2010).
22. Punkvang, A. et al. Investigating the structural basis of arylamides to improve potency against M.Tuberculosis strain through molecular dynamics simulations. European journal of medicinal chemistry 45, 5585-5593 (2010).
23. Scatchard, G. The Attraction of Proteins for Small Molecules and Ions. Annals of the New York Academy of Sciences 51, 660-672 (2006).
24. Eftink, M. R. & Ghiron, C. A. Fluorescence quenching studies with proteins. Analytical Biochemistry 114, 199-227 (1981).
25. Nguyen, H. M. & Graber, C. J. Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer? The Journal of antimicrobial chemotherapy 65, 24-36 (2010).
26. Hanson, M. R. & Chung, C. L. Antibiotic selection for MRSA: case presentations and review of the literature. Journal of drugs in dermatology: JDD 8, 281-286 (2009).
27. Rubinstein, E., Kollef, M. H. & Nathwani, D. Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 46 Suppl 5, S378-385 (2008).
28. Vandenesch, F., Lina, G. & Henry, T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: A redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol. 2, 12 (2012).
29. Li, M. et al. Evolution of virulence in epidemic community-Associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Academy of Sciences of the United States of America 106, 5883-5888 (2009).
30. Holden, M. T. et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proceedings of the National Academy of Sciences of the United States of America 101, 9786-9791 (2004).
31. Sonnen, A. F. & Henneke, P. Role of pore-forming toxins in neonatal sepsis. Clinical & developmental immunology 2013, 608456 (2013).
32. Ragle, B. E. & Bubeck Wardenburg, J. Anti-Alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infection and immunity 77, 2712-2718 (2009).
33. Qiu, J. et al. Capsaicin protects mice from community-Associated methicillin-resistant Staphylococcus aureus pneumonia. Plos one 7, e33032 (2012).
34. Xu, F. et al. Curcumin attenuates staphylococcus aureus-induced acute lung injury. The clinical respiratory journal 9, 87-97 (2015).
35. Ye, Y., Li, Y. & Fang, F. Upconversion nanoparticles conjugated with curcumin as a photosensitizer to inhibit methicillin-resistant Staphylococcus aureus in lung under near infrared light. International journal of nanomedicine 9, 5157-5165 (2014).
36. Subramani, P. A. & Narala, V. R. Challenges of curcumin bioavailability: novel aerosol remedies. Natural product communications 8, 121-124 (2013).
37. Kurien, B. T. & Scofield, R. H. Oral administration of heat-solubilized curcumin for potentially increasing curcumin bioavailability in experimental animals. International journal of cancer 125, 1992-1993 (2009).
38. Hess, B., Kutzner, C., Spoel, D. V. D. & Lindahl, E. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. Journal of Chemical Theory & Computation 4, 435-447 (2008).
39. Awad, R. A., Camacho, S., Santillan, C., Yanez, P. & Isidro, L. Insights into Nucleotide Recognition by Cell Division Protein FtsZ from a mant-GTP Competition Assay and Molecular Dynamics. Biochemistry 49, 10458-10472 (2010).
40. Auradee, P. et al. Investigating the structural basis of arylamides to improve potency against M.Tuberculosis strain through molecular dynamics simulations. European journal of medicinal chemistry 45, 5585-5593 (2010).